WeightWatchers own data shows people combining a GLP-1 with its program lose substantially more than with the app alone, which is the same story playing out across the whole industry: the medication is the main driver, and the behavioral program supports it
Call 911 or visit the nearest emergency room
What's clear from the long-term data is that adults who built sustainable training and nutrition habits during months 16 maintain their results dramatically better than those who relied on the peptide alone
They simply extend how long it remains active in your body
Reduced joint pain and improved mobility Every pound lost removes approximately four pounds of stress from the knee joints
Sources PubMed: Triple-Hormone-Receptor Agonist Retatrutide for Obesity Eli Lilly TRIUMPH-1 Phase 3 topline release, May 21, 2026 Lilly Medical: TRIUMPH clinical trial program overview ClinicalTrials.gov: NCT04881760 Phase 2 obesity trial PeptideStack page context: visitors can use the header navigation to reach the product catalog, blog, calculators, supplier pages, discount-code pages, contact page, legal policies, shipping policy, refund policy, privacy policy, terms, and research disclaimer